SCHEMBL7835902

SCHEMBL7835902

CCOC(=O)C1(C2Cc3c(C(=O)Nc4ccccc4)cccc3C2=O)N=CC=N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2R P25116 1/20 0.40
RAB9A P51151 3/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
CREBBP Q92793 3/20 0.38
BRD4 O60885 2/20 0.38
EPHX2 P34913 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 2/20 0.37
PTPN11 Q06124 2/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7844391 0.87 CREBBP (0.41) RAB9ACREBBPALDH1A1MEN1GAA
SCHEMBL7846408 0.84 PKM (0.34) RAB9APKMSMN1; SMN2NPC1ALDH1A1
SCHEMBL7847789 0.80 SMN1; SMN2 (0.41) RAB9AEPHX2SMN1; SMN2NPC1ALDH1A1
SCHEMBL7847297 0.71 CYP3A4 (0.51) CREBBPBRD4ALDH1A1MEN1KMT2A
SCHEMBL7835910 0.71 ALDH1A1 (0.43) RAB9APOLBPKMEPHX2SMN1; SMN2
SCHEMBL7845972 0.70 ALDH1A1 (0.44) EPHX2ALDH1A1MEN1GAAKMT2A
SCHEMBL7836093 0.63 CYP3A4 (0.57) SMN1; SMN2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL5224370 0.60 KCNK3 (0.62) RAB9APOLBSMN1; SMN2NPC1ALDH1A1
SCHEMBL1017795 0.60 CYP3A4 (0.89) POLBALDH1A1MEN1GAAKMT2A
SCHEMBL2151745 0.60 SMN1; SMN2 (0.51) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820455-B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES AVENTIS PHARMA SA (FR) 2001-10-31 EP disclosed
US-6057454-A USEFUL FOR TREATING OR PREVENTING ALL ISCHAEMIAS (SUCH AS FOCAL OR GLOBAL ISCHAEMIA) RESULTING FROM CEREBROVASCULAR DISORDERS RHONE-POULENC RORER S.A. (FR) 2000-05-02 US disclosed
US-5902803-A 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives RHONE-POULENC RORER S.A. (FR) 1999-05-11 US disclosed
EP-0820455-A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES Aventis Pharma S.A. (FR) 1998-01-28 EP disclosed
WO-1996031511-A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1996-10-10 WO disclosed